EssilorLuxottica Q1 sales rise driven by China, U.S. rebound By Reuters

2/2
© Reuters. FILE PHOTO: Sunglasses from Ray Ban are on display at a optician shop in Hanau near Frankfurt, Germany, March 18, 2016. REUTERS/Kai Pfaffenbach

2/2

(Reuters) -Oakley and Ray-Ban maker EssilorLuxottica’s first-quarter sales continued on the path to recovery from the impact of the COVID-19 pandemic, boosted by a strong rebound in China and the United States.

The company, which makes sunglasses and spectacle frames for brands such as Chanel, Prada (OTC:) and Versace, was hit by coronavirus lockdowns and travel curbs last year, which knocked demand for sunglasses in particular.

Sales in the first quarter jumped 14.3% at constant currencies from a year earlier to 4.06 billion euros ($4.9 billion).

EssilorLuxottica confirmed it targets a return to pre-pandemic levels this year. It also specified the 2021 target concerned revenue and adjusted operating profit margin.

First-quarter results were ahead of that goal as sales in the first quarter grew 1.9% over 2019 at constant currencies.

The company, formed from the merger of French lens manufacturer Essilor and Italian spectacles maker Luxottica, also confirmed it expects to deliver synergies from the merger of 300 million to 350 million euros in adjusted operating profit by the end of this year, and of 420 million to 600 million by the end of 2023.

($1=0.8331 euros)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*